首页 > 最新文献

Frontiers in Cellular and Infection Microbiology最新文献

英文 中文
Multiple Brucella melitensis lineages are driving the human brucellosis epidemic in Shaanxi Province, China: evidence from whole genome sequencing-based analysis. 多种布鲁氏菌系是中国陕西省人类布鲁氏菌病流行的驱动因素:基于全基因组测序分析的证据。
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-30 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1452143
Cuihong An, Shoumin Nie, Boyan Luo, Dijia Zhou, Wenjing Wang, Yangxin Sun, Suoping Fan, Dongli Liu, Zhenjun Li, Zhiguo Liu, Wenhui Chang

Introduction: Human brucellosis is a severe public concern in Shaanxi Province, China, and investigating the epidemiological relationship and transmission pattern of B. melitensis is necessary to devise control strategies.

Methods: In this study, a conventional bio-typing approach and whole genome sequencing of single-nucleotide polymorphisms (SNPs) were employed to identify 189 strains.

Results: Based on the conventional bio-typing, 189 Brucella strains were identified as B. melitensis, of which 14 were in bv. 1, 145 were in bv. 3, and 30 were variant, and the Brucella strains were distributed in all ten cities in Shaanxi Province. SNP analysis was used to identify genetic variation in 189 B. melitensis genomes, and maximum-likelihood was used to generate a phylogeny that identified two clades (A and B) and 19 sequence types (STs). The two clades were highly diverse and exclusively of Eastern Mediterranean origin. Clade B contained 18 STs (2-19), with most isolates originating from a broad swath, implying that multiple B. melitensis lineages circulated in Shaanxi. The 19 STs were composed of 3 to 46 strains isolated from different counties and years, suggesting that multiple cross-county brucellosis outbreak events are driven by multiple B. melitensis lineages. Global phylogenetic analysis revealed that clade A was close to GTIIb, and clade B was placed in the GTIIh lineage, expanding the known diversity of B. melitensis from China.

Conclusion: The human brucellosis epidemic in Shaanxi is driven by multiple indigenous circulating B. melitensis lineages, the knowledge of which will contribute to devising a control strategy and providing the foundation for a comprehensive regional phylogeny of this important zoonotic pathogen.

引言人类布鲁氏菌病在中国陕西省是一个严重的公共问题,调查布鲁氏菌的流行病学关系和传播模式对于制定控制策略非常必要:方法:本研究采用传统生物分型法和单核苷酸多态性(SNPs)全基因组测序法鉴定了189个菌株:结果:在传统生物分型的基础上,189株布鲁氏菌被鉴定为B. melitensis,其中14株为bv.1型,145株为bv.3型,30株为变异型,布鲁氏菌菌株分布在陕西省所有10个地市。利用SNP分析鉴定了189个布鲁氏菌基因组的遗传变异,并利用最大似然法建立了系统发育,确定了两个支系(A和B)和19个序列类型(ST)。这两个支系具有高度的多样性,且全部源自东地中海地区。支系B包含18个STs(2-19),大多数分离株来自一个广阔的区域,这意味着多个B. melitensis品系在陕西流通。这19个ST由分离自不同县和不同年份的3至46株菌株组成,表明多个跨县布鲁氏菌病暴发事件是由多个布鲁氏菌品系驱动的。全球系统进化分析表明,支系A与GTIIb接近,支系B被归入GTIIh系,从而扩大了中国布鲁氏菌的已知多样性:结论:陕西的人类布鲁氏菌病疫情是由多个本地流行的布鲁氏菌系驱动的,对这些系的了解将有助于制定控制策略,并为这一重要人畜共患病病原体的全面区域系统发育奠定基础。
{"title":"Multiple <i>Brucella melitensis</i> lineages are driving the human brucellosis epidemic in Shaanxi Province, China: evidence from whole genome sequencing-based analysis.","authors":"Cuihong An, Shoumin Nie, Boyan Luo, Dijia Zhou, Wenjing Wang, Yangxin Sun, Suoping Fan, Dongli Liu, Zhenjun Li, Zhiguo Liu, Wenhui Chang","doi":"10.3389/fcimb.2024.1452143","DOIUrl":"10.3389/fcimb.2024.1452143","url":null,"abstract":"<p><strong>Introduction: </strong>Human brucellosis is a severe public concern in Shaanxi Province, China, and investigating the epidemiological relationship and transmission pattern of <i>B. melitensis</i> is necessary to devise control strategies.</p><p><strong>Methods: </strong>In this study, a conventional bio-typing approach and whole genome sequencing of single-nucleotide polymorphisms (SNPs) were employed to identify 189 strains.</p><p><strong>Results: </strong>Based on the conventional bio-typing, 189 <i>Brucella</i> strains were identified as <i>B. melitensis</i>, of which 14 were in bv. 1, 145 were in bv. 3, and 30 were variant, and the <i>Brucella</i> strains were distributed in all ten cities in Shaanxi Province. SNP analysis was used to identify genetic variation in 189 <i>B. melitensis</i> genomes, and maximum-likelihood was used to generate a phylogeny that identified two clades (A and B) and 19 sequence types (STs). The two clades were highly diverse and exclusively of Eastern Mediterranean origin. Clade B contained 18 STs (2-19), with most isolates originating from a broad swath, implying that multiple <i>B. melitensis</i> lineages circulated in Shaanxi. The 19 STs were composed of 3 to 46 strains isolated from different counties and years, suggesting that multiple cross-county brucellosis outbreak events are driven by multiple <i>B. melitensis</i> lineages. Global phylogenetic analysis revealed that clade A was close to GTIIb, and clade B was placed in the GTIIh lineage, expanding the known diversity of <i>B. melitensis</i> from China.</p><p><strong>Conclusion: </strong>The human brucellosis epidemic in Shaanxi is driven by multiple indigenous circulating <i>B. melitensis</i> lineages, the knowledge of which will contribute to devising a control strategy and providing the foundation for a comprehensive regional phylogeny of this important zoonotic pathogen.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1452143"},"PeriodicalIF":4.6,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scalable solutions for global health: the SalivaDirect model. 可扩展的全球健康解决方案:SalivaDirect 模式。
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-29 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1446514
Anne L Wyllie, Brittany Choate, Laura Burke, Yasmine Ali

The COVID-19 pandemic caught the world unprepared. Large-scale testing efforts were urgently needed, and diagnostic strategies had to rapidly evolve in response to unprecedented worldwide demand. However, the rollout of diagnostic testing and screening for SARS-CoV-2 was often impeded by logistical challenges, including regulatory delays, workforce shortages, laboratory bottlenecks, and supply chain disruptions. Recognizing these hurdles early on, we developed a testing approach that supported frequent, repeat testing, particularly as communities reopened. We hypothesized and experimentally demonstrated that saliva was a suitable specimen for the detection of SARS-CoV-2. This finding was advanced into the development of open-source, extraction-free reverse transcription polymerase chain reaction protocols using readily available, "off-the-shelf" reagents and equipment for the direct detection of SARS-CoV-2 in saliva ("SalivaDirect''). Working with the US Food and Drug Administration (FDA), we established a novel regulatory framework wherein the FDA granted Emergency Use Authorization to Yale University to offer the SalivaDirect test protocol to high-complexity diagnostic laboratories (as designated by the Clinical Laboratory Improvement Amendments) with quality oversight provided by Yale. This grew into a network of more than 200 labs across the United States that, as of May 2024, resulted in over 6.5 million SARS-CoV-2 tests. By making the protocol flexible and open-source, laboratories were able to rapidly and economically scale testing using a simple, self-collected saliva specimen. Additionally, fostering a national network of laboratories enabled real-time exchanges, problem solving, and the development of community best practices. Preparing for the next pandemic, or simply the next seasonal epidemic, the SalivaDirect model of deploying a readily available, expandable solution and accompanying network provides a proven method for the successful implementation of pathogen testing in the United States and globally.

COVID-19 大流行让全世界措手不及。大规模的检测工作迫在眉睫,诊断策略必须迅速发展,以应对前所未有的全球需求。然而,SARS-CoV-2 诊断测试和筛查的推广往往受到后勤挑战的阻碍,包括监管延误、劳动力短缺、实验室瓶颈和供应链中断。我们很早就意识到了这些障碍,因此开发了一种支持频繁重复检测的检测方法,尤其是在社区重新开放时。我们假设并通过实验证明,唾液是检测 SARS-CoV-2 的合适样本。我们利用现成的试剂和设备,开发了开源、免提取的反转录聚合酶链反应方案,用于直接检测唾液中的 SARS-CoV-2 ("SalivaDirect")。我们与美国食品和药物管理局(FDA)合作,建立了一个新颖的监管框架,FDA 向耶鲁大学颁发了紧急使用授权,允许耶鲁大学向高复杂性诊断实验室(《临床实验室改进修正案》指定的实验室)提供 SalivaDirect 检测方案,并由耶鲁大学提供质量监督。截至 2024 年 5 月,该网络已发展成为一个由全美 200 多家实验室组成的网络,进行了 650 多万次 SARS-CoV-2 检测。通过灵活、开源的协议,实验室能够利用简单的自采唾液标本快速、经济地扩大检测规模。此外,全国实验室网络的建立还促进了实时交流、问题解决和社区最佳实践的发展。为了应对下一次大流行或季节性流行病,SalivaDirect 模式部署了随时可用、可扩展的解决方案和配套网络,为在美国和全球成功实施病原体检测提供了行之有效的方法。
{"title":"Scalable solutions for global health: the SalivaDirect model.","authors":"Anne L Wyllie, Brittany Choate, Laura Burke, Yasmine Ali","doi":"10.3389/fcimb.2024.1446514","DOIUrl":"https://doi.org/10.3389/fcimb.2024.1446514","url":null,"abstract":"<p><p>The COVID-19 pandemic caught the world unprepared. Large-scale testing efforts were urgently needed, and diagnostic strategies had to rapidly evolve in response to unprecedented worldwide demand. However, the rollout of diagnostic testing and screening for SARS-CoV-2 was often impeded by logistical challenges, including regulatory delays, workforce shortages, laboratory bottlenecks, and supply chain disruptions. Recognizing these hurdles early on, we developed a testing approach that supported frequent, repeat testing, particularly as communities reopened. We hypothesized and experimentally demonstrated that saliva was a suitable specimen for the detection of SARS-CoV-2. This finding was advanced into the development of open-source, extraction-free reverse transcription polymerase chain reaction protocols using readily available, \"off-the-shelf\" reagents and equipment for the direct detection of SARS-CoV-2 in saliva (\"SalivaDirect''). Working with the US Food and Drug Administration (FDA), we established a novel regulatory framework wherein the FDA granted Emergency Use Authorization to Yale University to offer the SalivaDirect test protocol to high-complexity diagnostic laboratories (as designated by the Clinical Laboratory Improvement Amendments) with quality oversight provided by Yale. This grew into a network of more than 200 labs across the United States that, as of May 2024, resulted in over 6.5 million SARS-CoV-2 tests. By making the protocol flexible and open-source, laboratories were able to rapidly and economically scale testing using a simple, self-collected saliva specimen. Additionally, fostering a national network of laboratories enabled real-time exchanges, problem solving, and the development of community best practices. Preparing for the next pandemic, or simply the next seasonal epidemic, the SalivaDirect model of deploying a readily available, expandable solution and accompanying network provides a proven method for the successful implementation of pathogen testing in the United States and globally.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1446514"},"PeriodicalIF":4.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and preliminary assessment of the iFIND TBR: all-in- one molecular diagnostic assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance. 开发和初步评估 iFIND TBR:用于快速检测结核分枝杆菌和利福平耐药性的一体化分子诊断测定。
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-29 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1439099
Xichao Ou, Zexuan Song, Ruida Xing, Bing Zhao, Shaojun Pei, Chong Teng, Lincai Zhang, Qian Sun, Fang Liu, Hui Xia, Yang Zhou, Yang Zheng, Yuanyuan Song, Zhiguo Zhang, Shengfen Wang, Richard Anthony, Yanlin Zhao

Introduction: Early and accurate diagnosis of tuberculosis (TB) is crucial for initiating timely treatment and preventing new infections. In this study, we introduced the iFIND TBR assay, an automated all-in-one tuberculosis detection approach that simultaneously detect Mycobacterium tuberculosis (MTB) and rifampicin (RIF) resistance.

Methods: The limits of detection (LOD), sensitivity, specificity, and RIF-R rpoB mutation detection of the iFIND TBR were tested on Mycobacterium tuberculosis DNA or sputum samples spiked with known numbers of M.tuberculosis H37Rv. Frozen clinical samples from patients suspected of having TB were also tested.

Results: The LOD of the iFIND TBR for MTB detection were 13.34 CFU/ml (95% CI, 11.71-16.47), and for RIF resistance was 109.79CFU/mL (95% CI, 95-138.19). The iFIND TBR assay accurately distinguish MTB strains from non-tuberculous mycobacteria (NTM) without any cross reactivity. Testing on 157 clinical sputum samples, compared with the bacteriologically TB standard, the overall sensitivity and specificity of the iFIND TBR was 100% (95%CI, 94.64, 100) and 85.29% (95% CI, 74.61, 92.72), respectively. When assessing RIF susceptibility, the iFIND TBR achieved a sensitivity of 98.15% (95% CI, 90.11-99.95) and a specificity of 85.71% (95% CI, 67.33-95.97), compared with phenotypic drug susceptibility testing. Discordant RIF susceptibility results were more frequently observed in samples exhibiting heteroresistance.

Discussion: These findings demonstrate that iFIND TBR assay performs well in detecting TB and RIF resistance, and shows promise as a point-of-care tool in resource-limited areas.

导言:结核病(TB)的早期准确诊断对于及时开始治疗和预防新的感染至关重要。在这项研究中,我们引入了 iFIND TBR 检测法,这是一种同时检测结核分枝杆菌(MTB)和利福平(RIF)耐药性的全自动一体化结核病检测方法:方法:在结核分枝杆菌 DNA 或痰样本中添加已知数量的结核分枝杆菌 H37Rv,测试 iFIND TBR 的检测限(LOD)、灵敏度、特异性和 RIF-R rpoB 突变检测。此外,还对疑似肺结核患者的冷冻临床样本进行了测试:iFIND TBR 检测 MTB 的 LOD 为 13.34 CFU/ml(95% CI,11.71-16.47),检测 RIF 耐药性的 LOD 为 109.79CFU/ml(95% CI,95-138.19)。iFIND TBR 检测能准确区分 MTB 菌株和非结核分枝杆菌(NTM),且无交叉反应。在对 157 份临床痰液样本进行检测时,与结核菌标准相比,iFIND TBR 的总体灵敏度和特异性分别为 100%(95%CI,94.64,100)和 85.29%(95%CI,74.61,92.72)。在评估 RIF 药敏性时,与表型药敏试验相比,iFIND TBR 的灵敏度为 98.15%(95%CI,90.11-99.95),特异度为 85.71%(95%CI,67.33-95.97)。在表现出异抗性的样本中,RIF药敏结果不一致的情况更为常见:这些研究结果表明,iFIND TBR 检测法在检测肺结核和 RIF 耐药性方面表现良好,有望成为资源有限地区的护理点工具。
{"title":"Development and preliminary assessment of the iFIND TBR: all-in- one molecular diagnostic assay for rapid detection of <i>Mycobacterium tuberculosis</i> and rifampicin resistance.","authors":"Xichao Ou, Zexuan Song, Ruida Xing, Bing Zhao, Shaojun Pei, Chong Teng, Lincai Zhang, Qian Sun, Fang Liu, Hui Xia, Yang Zhou, Yang Zheng, Yuanyuan Song, Zhiguo Zhang, Shengfen Wang, Richard Anthony, Yanlin Zhao","doi":"10.3389/fcimb.2024.1439099","DOIUrl":"https://doi.org/10.3389/fcimb.2024.1439099","url":null,"abstract":"<p><strong>Introduction: </strong>Early and accurate diagnosis of tuberculosis (TB) is crucial for initiating timely treatment and preventing new infections. In this study, we introduced the iFIND TBR assay, an automated all-in-one tuberculosis detection approach that simultaneously detect <i>Mycobacterium tuberculosis</i> (MTB) and rifampicin (RIF) resistance.</p><p><strong>Methods: </strong>The limits of detection (LOD), sensitivity, specificity, and RIF-R rpoB mutation detection of the iFIND TBR were tested on Mycobacterium tuberculosis DNA or sputum samples spiked with known numbers of M.tuberculosis H37Rv. Frozen clinical samples from patients suspected of having TB were also tested.</p><p><strong>Results: </strong>The LOD of the iFIND TBR for MTB detection were 13.34 CFU/ml (95% CI, 11.71-16.47), and for RIF resistance was 109.79CFU/mL (95% CI, 95-138.19). The iFIND TBR assay accurately distinguish MTB strains from non-tuberculous mycobacteria (NTM) without any cross reactivity. Testing on 157 clinical sputum samples, compared with the bacteriologically TB standard, the overall sensitivity and specificity of the iFIND TBR was 100% (95%CI, 94.64, 100) and 85.29% (95% CI, 74.61, 92.72), respectively. When assessing RIF susceptibility, the iFIND TBR achieved a sensitivity of 98.15% (95% CI, 90.11-99.95) and a specificity of 85.71% (95% CI, 67.33-95.97), compared with phenotypic drug susceptibility testing. Discordant RIF susceptibility results were more frequently observed in samples exhibiting heteroresistance.</p><p><strong>Discussion: </strong>These findings demonstrate that iFIND TBR assay performs well in detecting TB and RIF resistance, and shows promise as a point-of-care tool in resource-limited areas.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1439099"},"PeriodicalIF":4.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemokine profile in the serum of patients with leptospirosis. 钩端螺旋体病患者血清中的趋化因子谱。
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-29 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1484291
Iago H de Miranda Mariano, Roberta M Blanco, Camila Eulalio de Souza, Geovanna Silva de Freitas, Paulo Lee Ho, Elizabeth A L Martins, Eliete C Romero, Josefa B da Silva

Introduction: Leptospirosis is a global zoonosis that affects more than one million people per year, with a lethality rate of approximately 15%. Chemokines are crucial in the immune response against Leptospira, recruiting leukocytes to the site of infection and regulating immune activity. In previous studies, we have shown that CCL2, CXCL5, and CCL8 are involved in the leptospirosis process, although the mechanisms are not understood.

Methods: In this study, we present the frequency of Leptospira serovars in human samples. We then evaluated the profile of various chemokines in sera from patients diagnosed with leptospirosis, assessing the possible correlation between them. Moreover, we evaluated the changes in the chemokine profile on different days after the first symptoms. The frequency of the Leptospira serovars in human samples is presented.

Results and discussion: The main findings were that CCL5, CXCL5, and CXCL9 are highly expressed during leptospirosis, indicating a special role of these molecules in the immunity and pathogenesis of the disease. The correlation analysis of detected chemokines CXCL11, CXCL9, CCL3, and CCL2 helps to clarify the role of each cytokine in leptospirosis. The possible use of CCL5 as a biomarker for complementary diagnosis of the disease is suggested.

导言:钩端螺旋体病是一种全球性的人畜共患疾病,每年有 100 多万人感染,致死率约为 15%。趋化因子在针对钩端螺旋体的免疫反应中至关重要,它能将白细胞募集到感染部位并调节免疫活性。在之前的研究中,我们已经发现 CCL2、CXCL5 和 CCL8 参与了钩端螺旋体病的发病过程,但其机制尚不清楚:在本研究中,我们介绍了钩端螺旋体血清型在人体样本中的出现频率。然后,我们评估了确诊为钩端螺旋体病患者血清中各种趋化因子的概况,评估了它们之间可能存在的相关性。此外,我们还评估了首次出现症状后不同日子里趋化因子谱的变化。结果和讨论:主要发现是,CCL5、CXCL5 和 CXCL9 在钩端螺旋体病期间高表达,表明这些分子在免疫和疾病发病机制中的特殊作用。对检测到的趋化因子 CXCL11、CXCL9、CCL3 和 CCL2 的相关性分析有助于明确每种细胞因子在钩端螺旋体病中的作用。建议将 CCL5 用作辅助诊断该疾病的生物标志物。
{"title":"Chemokine profile in the serum of patients with leptospirosis.","authors":"Iago H de Miranda Mariano, Roberta M Blanco, Camila Eulalio de Souza, Geovanna Silva de Freitas, Paulo Lee Ho, Elizabeth A L Martins, Eliete C Romero, Josefa B da Silva","doi":"10.3389/fcimb.2024.1484291","DOIUrl":"https://doi.org/10.3389/fcimb.2024.1484291","url":null,"abstract":"<p><strong>Introduction: </strong>Leptospirosis is a global zoonosis that affects more than one million people per year, with a lethality rate of approximately 15%. Chemokines are crucial in the immune response against <i>Leptospira</i>, recruiting leukocytes to the site of infection and regulating immune activity. In previous studies, we have shown that CCL2, CXCL5, and CCL8 are involved in the leptospirosis process, although the mechanisms are not understood.</p><p><strong>Methods: </strong>In this study, we present the frequency of <i>Leptospira</i> serovars in human samples. We then evaluated the profile of various chemokines in sera from patients diagnosed with leptospirosis, assessing the possible correlation between them. Moreover, we evaluated the changes in the chemokine profile on different days after the first symptoms. The frequency of the <i>Leptospira</i> serovars in human samples is presented.</p><p><strong>Results and discussion: </strong>The main findings were that CCL5, CXCL5, and CXCL9 are highly expressed during leptospirosis, indicating a special role of these molecules in the immunity and pathogenesis of the disease. The correlation analysis of detected chemokines CXCL11, CXCL9, CCL3, and CCL2 helps to clarify the role of each cytokine in leptospirosis. The possible use of CCL5 as a biomarker for complementary diagnosis of the disease is suggested.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1484291"},"PeriodicalIF":4.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchoalveolar lavage fluid and lung biopsy tissue metagenomic next-generation sequencing in the diagnosis of pulmonary cryptococcosis. 支气管肺泡灌洗液和肺活检组织元基因组新一代测序在肺隐球菌病诊断中的应用。
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-29 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1446814
Jinbao Huang, Heng Weng, Ling Ye, Meiqin Jiang, Lulu Chen, Yangyu Li, Hongyan Li

Objective: To evaluate the diagnostic value of metagenomic next-generation sequencing (mNGS) in pulmonary cryptococcosis (PC) using bronchoalveolar lavage fluid (BALF) and lung biopsy tissue specimens.

Methods: In this retrospective study, 321 patients diagnosed with lower respiratory tract diseases who underwent mNGS using BALF and LBT samples, between January 2021 and December 2023 were included. Individuals were classified into PC and non-PC groups according to the diagnostic criteria for PC, and conventional fungal cultures were performed. A serum/BALF cryptococcal antigen (CrAg) test was performed in some patients with PC. The diagnostic efficiencies of three methods for PC (mNGS, conventional culture, and CrAg) were compared. Additionally, two mNGS methods were used in this study: original mNGS (OmNGS, testing time from January 2021 to December 2022) and modified mNGS (MmNGS, testing time from January to December 2023). The diagnostic efficiency of the two mNGS methods on PC was simultaneously compared.

Results: Among the 321 patients, 23 (7.2%) had PC and 298 (92.8%) did not. Compared with the composite reference standard for PC diagnosis, the sensitivity, specificity, and accuracy of mNGS for PC were 78.3% (95% confidence interval [CI], 55.8%-91.7%), 98.7% (95% CI, 96.4%-99.6%), and 97.2% (95% CI, 94.7%-98.7%), respectively. The sensitivity of mNGS was similar to that of CrAg (80.0%, 12/15) (P > 0.05). The diagnostic sensitivity of both mNGS and CrAg was higher than that of conventional culture (35.0%, 7/20) (P = 0.006, P = 0.016), and the combined detection of mNGS and CrAg further improved the diagnostic sensitivity of PC (93.3%, 14/15). The area under the receiver operating characteristic curve of mNGS was superior to that of conventional culture (0.885 vs. 0.675). In addition, the diagnostic sensitivity of PC was higher than that of OmNGS (P = 0.046).

Conclusion: The sensitivity of mNGS is better than that of conventional culture. The combination of mNGS and CrAg improves the testing sensitivity of Cryptococcus. MmNGS could further improve the detection of Cryptococcus. Conventional PC detection methods are indispensable and mNGS can be used as a rapid and accurate auxiliary diagnostic method for PC.

目的评估元基因组新一代测序(mNGS)使用支气管肺泡灌洗液(BALF)和肺活检组织标本对肺隐球菌病(PC)的诊断价值:在这项回顾性研究中,纳入了在 2021 年 1 月至 2023 年 12 月期间使用支气管肺泡灌洗液(BALF)和肺活检组织标本接受 mNGS 的 321 名确诊为下呼吸道疾病的患者。根据 PC 诊断标准将患者分为 PC 组和非 PC 组,并进行常规真菌培养。对部分 PC 患者进行了血清/BALF 隐球菌抗原(CrAg)检测。比较了三种 PC 诊断方法(mNGS、传统培养和 CrAg)的诊断效率。此外,本研究还采用了两种 mNGS 方法:原始 mNGS(OmNGS,检测时间为 2021 年 1 月至 2022 年 12 月)和改良 mNGS(MmNGS,检测时间为 2023 年 1 月至 12 月)。同时比较了两种 mNGS 方法对 PC 的诊断效率:在 321 名患者中,23 人(7.2%)患有 PC,298 人(92.8%)未患 PC。与 PC 诊断的复合参考标准相比,mNGS 对 PC 的敏感性、特异性和准确性分别为 78.3%(95% 置信区间 [CI],55.8%-91.7%)、98.7%(95% CI,96.4%-99.6%)和 97.2%(95% CI,94.7%-98.7%)。mNGS 的灵敏度与 CrAg 相似(80.0%,12/15)(P > 0.05)。mNGS 和 CrAg 的诊断灵敏度均高于传统培养(35.0%,7/20)(P = 0.006,P = 0.016),mNGS 和 CrAg 的联合检测进一步提高了 PC 的诊断灵敏度(93.3%,14/15)。mNGS 的接收器操作特征曲线下面积优于传统培养(0.885 对 0.675)。此外,PC 的诊断灵敏度高于 OmNGS(P = 0.046):结论:mNGS 的敏感性优于传统培养。结论:mNGS 的灵敏度优于传统培养,mNGS 与 CrAg 的结合提高了隐球菌的检测灵敏度。mNGS 可进一步提高隐球菌的检测率。传统的 PC 检测方法不可或缺,而 mNGS 可作为 PC 快速、准确的辅助诊断方法。
{"title":"Bronchoalveolar lavage fluid and lung biopsy tissue metagenomic next-generation sequencing in the diagnosis of pulmonary cryptococcosis.","authors":"Jinbao Huang, Heng Weng, Ling Ye, Meiqin Jiang, Lulu Chen, Yangyu Li, Hongyan Li","doi":"10.3389/fcimb.2024.1446814","DOIUrl":"https://doi.org/10.3389/fcimb.2024.1446814","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the diagnostic value of metagenomic next-generation sequencing (mNGS) in pulmonary cryptococcosis (PC) using bronchoalveolar lavage fluid (BALF) and lung biopsy tissue specimens.</p><p><strong>Methods: </strong>In this retrospective study, 321 patients diagnosed with lower respiratory tract diseases who underwent mNGS using BALF and LBT samples, between January 2021 and December 2023 were included. Individuals were classified into PC and non-PC groups according to the diagnostic criteria for PC, and conventional fungal cultures were performed. A serum/BALF cryptococcal antigen (CrAg) test was performed in some patients with PC. The diagnostic efficiencies of three methods for PC (mNGS, conventional culture, and CrAg) were compared. Additionally, two mNGS methods were used in this study: original mNGS (OmNGS, testing time from January 2021 to December 2022) and modified mNGS (MmNGS, testing time from January to December 2023). The diagnostic efficiency of the two mNGS methods on PC was simultaneously compared.</p><p><strong>Results: </strong>Among the 321 patients, 23 (7.2%) had PC and 298 (92.8%) did not. Compared with the composite reference standard for PC diagnosis, the sensitivity, specificity, and accuracy of mNGS for PC were 78.3% (95% confidence interval [CI], 55.8%-91.7%), 98.7% (95% CI, 96.4%-99.6%), and 97.2% (95% CI, 94.7%-98.7%), respectively. The sensitivity of mNGS was similar to that of CrAg (80.0%, 12/15) (<i>P</i> > 0.05). The diagnostic sensitivity of both mNGS and CrAg was higher than that of conventional culture (35.0%, 7/20) (<i>P</i> = 0.006, <i>P</i> = 0.016), and the combined detection of mNGS and CrAg further improved the diagnostic sensitivity of PC (93.3%, 14/15). The area under the receiver operating characteristic curve of mNGS was superior to that of conventional culture (0.885 vs. 0.675). In addition, the diagnostic sensitivity of PC was higher than that of OmNGS (<i>P</i> = 0.046).</p><p><strong>Conclusion: </strong>The sensitivity of mNGS is better than that of conventional culture. The combination of mNGS and CrAg improves the testing sensitivity of <i>Cryptococcus</i>. MmNGS could further improve the detection of <i>Cryptococcus</i>. Conventional PC detection methods are indispensable and mNGS can be used as a rapid and accurate auxiliary diagnostic method for PC.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1446814"},"PeriodicalIF":4.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554620/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IFN-treated macrophage-derived exosomes prevents HBV-HCC migration and invasion via regulating miR-106b-3p/PCGF3/PI3K/AKT signaling axis. 经 IFN 处理的巨噬细胞衍生外泌体可通过调节 miR-106b-3p/PCGF3/PI3K/AKT 信号轴阻止 HBV-HCC 迁移和侵袭。
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-28 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1421195
Jing Chen, Qi Yin, Shiheng Xu, Xiaoqing Tan, Yu Liang, Chaohui Chen, Li Li, Tao Zhang, Tao Shen

Background: Studies revealed that exosomes from IFN-α-treated liver non-parenchymal cells (IFN-exo) mediate antiviral activity. MiR-106b-3p has been shown to play a paradoxical role in disease progressing from different studies. However, its specific role in HBV-related hepatocellular carcinoma (HBV-HCC) and the underlying mechanism remains unclear.

Method: Huh7 cells transient transfected with plasmids of HBV-C2 and B3 were co-cultured with IFN-exo. Cell supernatants were collected to detect miR-106b-3p, HBsAg, HBeAg and HBV DNA levels. Cell proliferation, apoptosis, migration and invasion were analyzed. The putative targets of miR-106b-3p were identified by a dual-luciferase reporter system. The expression of PCGF3, migratory proteins(MMP2/9), and the PI3K/AKT signaling pathway-related proteins were assessed by western blot. The expression of PCGF3 mRNA was quantitative analyzed by using 52 pairs of paraffin-embedded tissues from HCC patients. siRNAs-PCGF3 were used to knocked-down PCGF3 expression.

Results: The expression of miR-106b-3p was significantly higher in THP-1 cells and supernatants treated with IFN-exo than those untreated. Significantly increased expression of miR-106b-3p and decreased expression of HBsAg and HBV DNA were observed in Huh7-C2/B3 cells treated with IFN-exo. In addition, miR-106b-3p was directly target to PCGF3. Scratch healing assay and transwell assay showed that either IFN-exo or miRNA-106-3p over-expression, or siRNAs-PCGF3 inhibited migration and invasion of Huh7-C2/B3 cells, and subsequently resulted in suppression of p-AKT/AKT and p-PI3K/PI3K. Notably, the expression level of PCGF3 was significantly lower in HBeAg (+)-HCC tumor tissues than HBeAg (-)-HCC tumor.

Conclusion: IFN-α-induced macrophage-derived miR-106b-3p inhibits HBV replication, HBV- Huh7 cells migration and invasion via regulating PCGF3/PI3K/AKT signaling axis. miR-106b-3p and PCGF3 were potential biomarkers in the prevention and treatment of HBV-HCC.

背景:研究发现,来自经IFN-α处理的肝脏非实质性细胞(IFN-exo)的外泌体具有抗病毒活性。不同的研究表明,MiR-106b-3p 在疾病进展中发挥着矛盾的作用。然而,它在 HBV 相关肝细胞癌(HBV-HCC)中的具体作用及其内在机制仍不清楚:方法:将瞬时转染有 HBV-C2 和 B3 质粒的 Huh7 细胞与 IFN-exo 共同培养。收集细胞上清以检测 miR-106b-3p、HBsAg、HBeAg 和 HBV DNA 水平。对细胞增殖、凋亡、迁移和侵袭进行了分析。通过双荧光素酶报告系统确定了 miR-106b-3p 的假定靶标。用 Western 印迹法评估了 PCGF3、迁移蛋白(MMP2/9)和 PI3K/AKT 信号通路相关蛋白的表达。使用 siRNAs-PCGF3 敲低 PCGF3 的表达:结果:经 IFN-exo 处理的 THP-1 细胞和上清液中 miR-106b-3p 的表达明显高于未处理的细胞和上清液。经 IFN-exo 处理的 Huh7-C2/B3 细胞中,miR-106b-3p 的表达明显增加,HBsAg 和 HBV DNA 的表达减少。此外,miR-106b-3p 是 PCGF3 的直接靶标。划痕愈合试验和透孔试验表明,IFN-exo或miRNA-106-3p过表达,或siRNAs-PCGF3都能抑制Huh7-C2/B3细胞的迁移和侵袭,并随后导致p-AKT/AKT和p-PI3K/PI3K的抑制。值得注意的是,PCGF3在HBeAg(+)-HCC肿瘤组织中的表达水平明显低于HBeAg(-)-HCC肿瘤:IFN-α诱导的巨噬细胞源miR-106b-3p通过调节PCGF3/PI3K/AKT信号轴抑制HBV复制、HBV- Huh7细胞迁移和侵袭。
{"title":"IFN-treated macrophage-derived exosomes prevents HBV-HCC migration and invasion via regulating miR-106b-3p/PCGF3/PI3K/AKT signaling axis.","authors":"Jing Chen, Qi Yin, Shiheng Xu, Xiaoqing Tan, Yu Liang, Chaohui Chen, Li Li, Tao Zhang, Tao Shen","doi":"10.3389/fcimb.2024.1421195","DOIUrl":"https://doi.org/10.3389/fcimb.2024.1421195","url":null,"abstract":"<p><strong>Background: </strong>Studies revealed that exosomes from IFN-α-treated liver non-parenchymal cells (IFN-exo) mediate antiviral activity. MiR-106b-3p has been shown to play a paradoxical role in disease progressing from different studies. However, its specific role in HBV-related hepatocellular carcinoma (HBV-HCC) and the underlying mechanism remains unclear.</p><p><strong>Method: </strong>Huh7 cells transient transfected with plasmids of HBV-C2 and B3 were co-cultured with IFN-exo. Cell supernatants were collected to detect miR-106b-3p, HBsAg, HBeAg and HBV DNA levels. Cell proliferation, apoptosis, migration and invasion were analyzed. The putative targets of miR-106b-3p were identified by a dual-luciferase reporter system. The expression of PCGF3, migratory proteins(MMP2/9), and the PI3K/AKT signaling pathway-related proteins were assessed by western blot. The expression of PCGF3 mRNA was quantitative analyzed by using 52 pairs of paraffin-embedded tissues from HCC patients. siRNAs-PCGF3 were used to knocked-down PCGF3 expression.</p><p><strong>Results: </strong>The expression of miR-106b-3p was significantly higher in THP-1 cells and supernatants treated with IFN-exo than those untreated. Significantly increased expression of miR-106b-3p and decreased expression of HBsAg and HBV DNA were observed in Huh7-C2/B3 cells treated with IFN-exo. In addition, miR-106b-3p was directly target to PCGF3. Scratch healing assay and transwell assay showed that either IFN-exo or miRNA-106-3p over-expression, or siRNAs-PCGF3 inhibited migration and invasion of Huh7-C2/B3 cells, and subsequently resulted in suppression of p-AKT/AKT and p-PI3K/PI3K. Notably, the expression level of PCGF3 was significantly lower in HBeAg (+)-HCC tumor tissues than HBeAg (-)-HCC tumor.</p><p><strong>Conclusion: </strong>IFN-α-induced macrophage-derived miR-106b-3p inhibits HBV replication, HBV- Huh7 cells migration and invasion via regulating PCGF3/PI3K/AKT signaling axis. miR-106b-3p and PCGF3 were potential biomarkers in the prevention and treatment of HBV-HCC.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1421195"},"PeriodicalIF":4.6,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11551115/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nitric oxide-producing monocyte-myeloid suppressor cells expand and accumulate in the spleen and mesenteric lymph nodes of Yersinia enterocolitica-infected mice. 产生一氧化氮的单核-髓系抑制细胞在感染耶尔森氏菌的小鼠脾脏和肠系膜淋巴结中扩张和聚集。
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-28 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1440514
Marianela Leporati, María Silvia Di Genaro, Ricardo Javier Eliçabe

Introduction: Yersinia enterocolitica (Ye) is a Gram-negative bacterium that causes gastrointestinal infections. The myeloid-derived suppressor cells (MDSCs) constitute a cellular population with the capacity of inducing the specific suppression of T cells. Although there is evidence supporting the role of MDSCs in controlling the immune responses in several bacterial infections, its role during Ye infection has not yet been reported. Therefore, the purpose of the present work was to analyze MDSCs after oral Ye infection.

Methods: C57BL/6 wild-type mice were infected with Ye WAP-314 serotype O:8. The proliferation of splenocytes and mesenteric lymph nodes (MLN) cells was measured as well as the levels of cytokines and nitric oxide (NO) in culture supernatants. The frequency and subsets of MDSCs were analyzed in the intestinal mucosa and spleen by flow cytometry. Furthermore, monocytic-MDSCs (Mo-MDSCs) and polymorphonuclear-MDSCs (PMN-MDSCs) were purified from the spleen of infected mice and their suppressor activity was evaluated in co-cultures with purified T cells.

Results: we observed a marked expansion of CD11b+Gr-1+ cells, a phenotype consistent with MDSCs, in the spleen and intestinal mucosa of Ye-infected mice. Interestingly, a robust proliferation of splenocytes and MLN cells was observed only when the MDSCs were depleted or the NO production was blocked. In addition, we determined that only Mo-MDSCs had the ability to suppress T-cell proliferation.

Conclusion: Our results highlight a mechanism by which Ye may induce suppression of the immune responses. We suggest that NO-producing Mo-MDSCs expand and accumulate in MLN and spleen of Ye-infected mice. These cells can then suppress the T-cell function without interfering with the anti-bacterial effector response. Instead, these immature myeloid cells may perform an important function in regulating the inflammatory response and protecting affected tissues.

导言:小肠结肠炎耶尔森菌(Yersinia enterocolitica,Ye)是一种革兰氏阴性细菌,可引起胃肠道感染。髓源性抑制细胞(MDSCs)是一种具有特异性抑制 T 细胞能力的细胞群。虽然有证据支持 MDSCs 在多种细菌感染中控制免疫反应的作用,但其在 Ye 感染中的作用尚未见报道。因此,本研究的目的是分析口服 Ye 感染后的 MDSCs:方法:用 Ye WAP-314 血清型 O:8 感染 C57BL/6 野生型小鼠。方法:用 Ye WAP-314 血清型 O:8 感染 C57BL/6 野生型小鼠,测定脾细胞和肠系膜淋巴结(MLN)细胞的增殖以及培养上清液中细胞因子和一氧化氮(NO)的水平。流式细胞术分析了肠粘膜和脾脏中 MDSCs 的频率和亚群。此外,还从感染小鼠的脾脏中纯化了单核-MDSCs(Mo-MDSCs)和多形核-MDSCs(PMN-MDSCs),并在与纯化的 T 细胞共培养时评估了它们的抑制活性。有趣的是,只有当 MDSCs 被耗竭或 NO 生成被阻断时,才能观察到脾脏细胞和 MLN 细胞的大量增殖。此外,我们还发现只有Mo-MDSCs具有抑制T细胞增殖的能力:我们的研究结果强调了叶可诱导抑制免疫反应的机制。我们认为,产生 NO 的 Mo-MDSCs 会在 Ye 感染小鼠的 MLN 和脾脏中扩增和积累。这些细胞可抑制 T 细胞功能,但不会干扰抗菌效应反应。相反,这些未成熟髓系细胞可能在调节炎症反应和保护受影响组织方面发挥重要功能。
{"title":"Nitric oxide-producing monocyte-myeloid suppressor cells expand and accumulate in the spleen and mesenteric lymph nodes of <i>Yersinia enterocolitica</i>-infected mice.","authors":"Marianela Leporati, María Silvia Di Genaro, Ricardo Javier Eliçabe","doi":"10.3389/fcimb.2024.1440514","DOIUrl":"https://doi.org/10.3389/fcimb.2024.1440514","url":null,"abstract":"<p><strong>Introduction: </strong><i>Yersinia enterocolitica</i> (Ye) is a Gram-negative bacterium that causes gastrointestinal infections. The myeloid-derived suppressor cells (MDSCs) constitute a cellular population with the capacity of inducing the specific suppression of T cells. Although there is evidence supporting the role of MDSCs in controlling the immune responses in several bacterial infections, its role during Ye infection has not yet been reported. Therefore, the purpose of the present work was to analyze MDSCs after oral Ye infection.</p><p><strong>Methods: </strong>C57BL/6 wild-type mice were infected with Ye WAP-314 serotype O:8. The proliferation of splenocytes and mesenteric lymph nodes (MLN) cells was measured as well as the levels of cytokines and nitric oxide (NO) in culture supernatants. The frequency and subsets of MDSCs were analyzed in the intestinal mucosa and spleen by flow cytometry. Furthermore, monocytic-MDSCs (Mo-MDSCs) and polymorphonuclear-MDSCs (PMN-MDSCs) were purified from the spleen of infected mice and their suppressor activity was evaluated in co-cultures with purified T cells.</p><p><strong>Results: </strong>we observed a marked expansion of CD11b+Gr-1+ cells, a phenotype consistent with MDSCs, in the spleen and intestinal mucosa of Ye-infected mice. Interestingly, a robust proliferation of splenocytes and MLN cells was observed only when the MDSCs were depleted or the NO production was blocked. In addition, we determined that only Mo-MDSCs had the ability to suppress T-cell proliferation.</p><p><strong>Conclusion: </strong>Our results highlight a mechanism by which Ye may induce suppression of the immune responses. We suggest that NO-producing Mo-MDSCs expand and accumulate in MLN and spleen of Ye-infected mice. These cells can then suppress the T-cell function without interfering with the anti-bacterial effector response. Instead, these immature myeloid cells may perform an important function in regulating the inflammatory response and protecting affected tissues.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1440514"},"PeriodicalIF":4.6,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11551114/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-frequency or contrary? The effects of Qiwei Baizhu Powder and its bioactive compounds on mucosa-associated microbiota of mice with antibiotic-associated diarrhea. 同频还是相反?七味白术粉及其生物活性化合物对抗生素相关性腹泻小鼠黏膜相关微生物群的影响
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-28 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1483048
Zeli Zhang, Yan Yang, Yingsi Zhang, Guozhen Xie

Qiwei Baizhu Powder (QWBZP) has been proven effective in treating antibiotic-associated diarrhea (AAD), and the mechanism is associated with regulating the gut microbiota. However, the role of the bioactive compounds of QWBZP in regulating the gut microbiota is still unclear. In this study, 24 mice were divided into a normal control group (N), a model group (R), a QWBZP decoction group (TW), and a QWBZP-TG group (TG). AAD mouse models were established by mixed antibiotic administration. After modeling, mice in the TW group and TG group were treated with QWBZP decoction and QWBZP-TG, respectively. Mice in the N group and R group were gavaged with sterile water. 16S rRNA gene sequencing was used to investigate the changes of mucosa-associated microbiota (MAM) in the small intestine of mice. Moreover, the levels of diamine oxidase (DAO), D-Lactate, secretory immunoglobulin A (sIgA), interleukin 6 (IL-6), IL-10, and tumor necrosis factor-α (TNF-α) were detected using enzyme-linked immunosorbent assay (ELISA) kits. The results showed that QWBZP-TG significantly altered the diversity, structure, and abundance of MAM in the AAD mice. QWBZP-TG exerted a stronger suppression effect on Escherichia and Clostridium compared with QWBZP decoction. Meanwhile, QWBZP-TG downregulated the abundance of Lactobacillus, which elicited an opposite effect to QWBZP decoction. Prevotella was the signature bacteria that responded to the QWBZP-TG intervention. Furthermore, both QWBZP decoction and QWBZP-TG decreased the levels of DAO, D-Lactate, sIgA, IL-6, and TNF-α in the AAD mice. The role of glycosides is to help QWBZP ameliorate diarrhea symptoms by inhibiting the proliferation of diarrhea-associated bacteria, reducing inflammation and regulating immunity.

七味白术散(QWBZP)已被证实能有效治疗抗生素相关性腹泻(AAD),其机制与调节肠道微生物群有关。然而,QWBZP 的生物活性化合物在调节肠道微生物群方面的作用仍不清楚。本研究将 24 只小鼠分为正常对照组(N)、模型组(R)、QWBZP 煎剂组(TW)和 QWBZP-TG 组(TG)。AAD 小鼠模型通过混合抗生素给药建立。建模后,TW 组和 TG 组小鼠分别接受 QWBZP 煎剂和 QWBZP-TG 治疗。N 组和 R 组小鼠用无菌水灌胃。采用 16S rRNA 基因测序法研究小鼠小肠粘膜相关微生物群(MAM)的变化。此外,还使用酶联免疫吸附试验(ELISA)试剂盒检测了二胺氧化酶(DAO)、D-乳酸盐、分泌型免疫球蛋白 A(sIgA)、白细胞介素 6(IL-6)、IL-10 和肿瘤坏死因子-α(TNF-α)的水平。结果表明,QWBZP-TG能显著改变AAD小鼠体内MAM的多样性、结构和丰度。与QWBZP煎剂相比,QWBZP-TG对埃希氏菌和梭状芽孢杆菌有更强的抑制作用。同时,QWBZP-TG 降低了乳酸杆菌的数量,与 QWBZP 煎剂的效果相反。Prevotella 是对 QWBZP-TG 干预产生反应的标志性细菌。此外,QWBZP煎剂和QWBZP-TG都能降低AAD小鼠体内DAO、D-乳酸、sIgA、IL-6和TNF-α的水平。苷的作用是通过抑制腹泻相关细菌的增殖、减轻炎症反应和调节免疫力来帮助 QWBZP 改善腹泻症状。
{"title":"Co-frequency or contrary? The effects of Qiwei Baizhu Powder and its bioactive compounds on mucosa-associated microbiota of mice with antibiotic-associated diarrhea.","authors":"Zeli Zhang, Yan Yang, Yingsi Zhang, Guozhen Xie","doi":"10.3389/fcimb.2024.1483048","DOIUrl":"https://doi.org/10.3389/fcimb.2024.1483048","url":null,"abstract":"<p><p>Qiwei Baizhu Powder (QWBZP) has been proven effective in treating antibiotic-associated diarrhea (AAD), and the mechanism is associated with regulating the gut microbiota. However, the role of the bioactive compounds of QWBZP in regulating the gut microbiota is still unclear. In this study, 24 mice were divided into a normal control group (N), a model group (R), a QWBZP decoction group (TW), and a QWBZP-TG group (TG). AAD mouse models were established by mixed antibiotic administration. After modeling, mice in the TW group and TG group were treated with QWBZP decoction and QWBZP-TG, respectively. Mice in the N group and R group were gavaged with sterile water. 16S rRNA gene sequencing was used to investigate the changes of mucosa-associated microbiota (MAM) in the small intestine of mice. Moreover, the levels of diamine oxidase (DAO), D-Lactate, secretory immunoglobulin A (sIgA), interleukin 6 (IL-6), IL-10, and tumor necrosis factor-α (TNF-α) were detected using enzyme-linked immunosorbent assay (ELISA) kits. The results showed that QWBZP-TG significantly altered the diversity, structure, and abundance of MAM in the AAD mice. QWBZP-TG exerted a stronger suppression effect on <i>Escherichia</i> and <i>Clostridium</i> compared with QWBZP decoction. Meanwhile, QWBZP-TG downregulated the abundance of <i>Lactobacillus</i>, which elicited an opposite effect to QWBZP decoction. <i>Prevotella</i> was the signature bacteria that responded to the QWBZP-TG intervention. Furthermore, both QWBZP decoction and QWBZP-TG decreased the levels of DAO, D-Lactate, sIgA, IL-6, and TNF-α in the AAD mice. The role of glycosides is to help QWBZP ameliorate diarrhea symptoms by inhibiting the proliferation of diarrhea-associated bacteria, reducing inflammation and regulating immunity.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1483048"},"PeriodicalIF":4.6,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11551125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and characterization of LuxR solo homolog PplR in pathogenic Pseudomonas plecoglossicida NB2011. 致病性胸膜假单胞菌 NB2011 中的 LuxR solo 同源物 PplR 的鉴定和特征描述。
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1458976
Shanshan Li, Tingting Jia, Yu Chi, Jigang Chen, Zhijuan Mao

Pseudomonas plecoglossicida is a causative agent of visceral granulomas in large yellow croaker (Larimichthys crocea). Quorum sensing (QS) is widely involved in imparting virulence to pathogenic bacteria; however, it has not been studied in P. plecoglossicida. In this study, we annotated a LuxR family transcriptional regulator in P. plecoglossicida NB2011 and designated as PplR. We aligned the protein sequence by BlastP and Clustal X2, monitored the N-acyl-homoserine lactone (AHL) signal production through cross-feeding bioassay and HC-MS/MS; investigated exogenous AHL signal binding by recombinant expression and thin layer chromatography; constructed a deletion mutant of the target gene by method of double homologous recombination; sequenced the transcript RNA and analyzed the data; additionally, characterized phenotypes of wild type and mutant strain. The LuxR homolog PplR was found to share high similarity with PpoR-the LuxR solo of Pseudomonas putida-without a cognate LuxI. The wild-type strain did not produce any AHL signals and the recombinant LuxR protein was found to bind C6-L-homoserine lactone (C6-HSL), C8-HSL, 3-oxo-C10-HSL, and 3-oxo-C12-HSL. RNA-seq analysis indicated 84 differentially expressed genes-5 upregulated and 79 downregulated-mainly enriched in gene ontology terms, such as flagella-dependent motility, integral component of membrane, DNA binding and transcription, and metal ion binding, suggesting that PplR is a master transcription regulator. The mutant strain showed attenuated biofilm-forming ability and stress resistance, and the data support a role for PplR in the regulation of these traits in P. plecoglossicida NB2011 independent of the presence of AHL signals. This is the first study to provide QS-related information on P. plecoglossicida.

plecoglossicida 假单胞菌是大黄鱼(Larimichthys crocea)内脏肉芽肿的致病菌。法定量感应(QS)广泛参与了病原菌毒力的传递,但尚未对胸膜假单胞菌进行研究。在本研究中,我们注释了 P. plecoglossicida NB2011 中的一个 LuxR 家族转录调控因子,并将其命名为 PplR。我们通过BlastP和Clustal X2对蛋白序列进行了比对,通过交叉饲养生物测定和HC-MS/MS监测了N-酰基高丝氨酸内酯(AHL)信号的产生,通过重组表达和薄层色谱研究了外源AHL信号的结合,通过双同源重组方法构建了目标基因缺失突变体,对转录本RNA进行了测序和数据分析,并对野生型和突变株进行了表型鉴定。结果发现,LuxR同源物PplR与普氏假单胞菌的LuxR单体PpoR高度相似,但没有同源的LuxI。野生型菌株不产生任何 AHL 信号,重组的 LuxR 蛋白可结合 C6-L-高丝氨酸内酯(C6-HSL)、C8-HSL、3-氧代-C10-HSL 和 3-氧代-C12-HSL。RNA-seq分析显示有84个差异表达基因--5个上调,79个下调--主要富集在基因本体术语中,如依赖鞭毛的运动、膜的整体成分、DNA结合和转录、金属离子结合等,表明PplR是一个主转录调节因子。突变菌株的生物膜形成能力和抗应激能力减弱,这些数据支持了 PplR 在 P. plecoglossicida NB2011 这些性状的调控中的作用,而与 AHL 信号的存在无关。这是第一项提供 P. plecoglossicida QS 相关信息的研究。
{"title":"Identification and characterization of LuxR solo homolog PplR in pathogenic <i>Pseudomonas plecoglossicida</i> NB2011.","authors":"Shanshan Li, Tingting Jia, Yu Chi, Jigang Chen, Zhijuan Mao","doi":"10.3389/fcimb.2024.1458976","DOIUrl":"https://doi.org/10.3389/fcimb.2024.1458976","url":null,"abstract":"<p><p><i>Pseudomonas plecoglossicida</i> is a causative agent of visceral granulomas in large yellow croaker (<i>Larimichthys crocea</i>). Quorum sensing (QS) is widely involved in imparting virulence to pathogenic bacteria; however, it has not been studied in <i>P. plecoglossicida</i>. In this study, we annotated a LuxR family transcriptional regulator in <i>P. plecoglossicida</i> NB2011 and designated as PplR. We aligned the protein sequence by BlastP and Clustal X2, monitored the N-acyl-homoserine lactone (AHL) signal production through cross-feeding bioassay and HC-MS/MS; investigated exogenous AHL signal binding by recombinant expression and thin layer chromatography; constructed a deletion mutant of the target gene by method of double homologous recombination; sequenced the transcript RNA and analyzed the data; additionally, characterized phenotypes of wild type and mutant strain. The LuxR homolog PplR was found to share high similarity with PpoR-the LuxR solo of <i>Pseudomonas putida</i>-without a cognate LuxI. The wild-type strain did not produce any AHL signals and the recombinant LuxR protein was found to bind C6-L-homoserine lactone (C6-HSL), C8-HSL, 3-oxo-C10-HSL, and 3-oxo-C12-HSL. RNA-seq analysis indicated 84 differentially expressed genes-5 upregulated and 79 downregulated-mainly enriched in gene ontology terms, such as flagella-dependent motility, integral component of membrane, DNA binding and transcription, and metal ion binding, suggesting that PplR is a master transcription regulator. The mutant strain showed attenuated biofilm-forming ability and stress resistance, and the data support a role for PplR in the regulation of these traits in <i>P. plecoglossicida</i> NB2011 independent of the presence of AHL signals. This is the first study to provide QS-related information on <i>P. plecoglossicida</i>.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1458976"},"PeriodicalIF":4.6,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum: Development and validation of next-generation sequencing panel for personalized Helicobacter pylori eradication treatment targeting multiple species. 更正:开发和验证用于针对多种幽门螺旋杆菌的个性化根除治疗的新一代测序面板。
IF 4.6 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI: 10.3389/fcimb.2024.1502072
Byung-Joo Min, Myung-Eui Seo, Jung Ho Bae, Ji Won Kim, Ju Han Kim

[This corrects the article DOI: 10.3389/fcimb.2024.1379790.].

[此处更正了文章 DOI:10.3389/fcimb.2024.1379790]。
{"title":"Corrigendum: Development and validation of next-generation sequencing panel for personalized <i>Helicobacter pylori</i> eradication treatment targeting multiple species.","authors":"Byung-Joo Min, Myung-Eui Seo, Jung Ho Bae, Ji Won Kim, Ju Han Kim","doi":"10.3389/fcimb.2024.1502072","DOIUrl":"https://doi.org/10.3389/fcimb.2024.1502072","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fcimb.2024.1379790.].</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"14 ","pages":"1502072"},"PeriodicalIF":4.6,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Cellular and Infection Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1